Thrombotic Thrombocytopenic Purpura

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Octapharma
OctapharmaAustria - Vienna
2 programs
OctaplasN/A1 trial
octaplasLG®N/A1 trial
Active Trials
NCT01938404Terminated1Est. Aug 2017
NCT03369314Completed263Est. Jan 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OctapharmaoctaplasLG®
OctapharmaOctaplas

Clinical Trials (2)

Total enrollment: 264 patients across 2 trials

Observational Study of the Use of octaplasLG®.

Start: Mar 2018Est. completion: Jan 2021263 patients
N/ACompleted

Octaplas Adult TTP Trial

Start: Jun 2017Est. completion: Aug 20171 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space